Latest fiscal year 2025 · computed deterministically from XBRL 10-K data · coverage 100%
In fiscal 2025, Astrana Health, Inc. reported revenue of $3.18B, up 56.4% year over year. Operating margin was 2.5% and net margin 0.7%, on a free-cash-flow margin of 3.3% with capital expenditure at 0.3% of revenue. Every figure is computed directly from ASTH's SEC XBRL 10-K filing — deterministic, with no estimates.
| Fiscal year | Revenue | Op margin | Net margin |
|---|---|---|---|
| FY2025 | $3.18B | 2.5% | 0.7% |
| FY2024 | $2.03B | 4.4% | 2.1% |
| FY2023 | $1.39B | 6.1% | 4.4% |
| FY2022 | $1.14B | 9.1% | 3.9% |
| FY2021 | $774M | 12.7% | 8.9% |
How does ASTH compare against its actual peer set?
A CompsDesk subscription covers unlimited benchmark packs on any covered company: up to 23 metrics (6 core guaranteed) × up to 5 fiscal years × up to 12 chosen peers, percentile placement, the subject's figures cited to their SEC tag, form and period with every company identified by its CIK, PDF-ready HTML + CSV, generated on demand.
Related in the same sector: IQV · ACM · BAH · ICLR · PAYX · IT
See ASTH benchmarked against two sector peers (free) →
Source: SEC EDGAR XBRL (10-K filings), latest filed values. "n/a" = not disclosed under mapped tags — never estimated. Informational benchmarking, not investment advice. © CompsDesk / Sam Arora.